However, supplementation of CCFM683 can prevent CRC by producing CLA in the intestine to regulate cytokines, inhibit the NF-κB signaling pathway, up-regulate intestinal TJ proteins and MUC2, and regulate gut microbiota, and all these effects were PPAR-γ dependent. The gene discussed is MUC2; the disease is colorectal carcinoma.